home / stock / rcus / rcus message board
Subject | By | Source | When |
---|---|---|---|
Biotechs are starting to react to news...finally. | conix | investorshub | 04/05/2022 3:26:51 PM |
The stock didn't react as well as expected | dinogreeves | investorshub | 05/27/2020 12:46:59 PM |
Also in the DEF 14.....didnt see any information | lovetc | investorshub | 04/22/2020 2:48:12 AM |
shorted some and bought some put at $31 | lovetc | investorshub | 04/22/2020 2:46:30 AM |
RCUS will likely hit 40 this week and | dinogreeves | investorshub | 04/21/2020 1:25:35 AM |
Bought another 1000 shares on that dip, going | dinogreeves | investorshub | 04/20/2020 10:14:42 PM |
Possible huge asset buy, or outright buyout coming | dinogreeves | investorshub | 04/20/2020 9:11:15 PM |
RCUS getting ready to pop to 33-35 dollars. | dinogreeves | investorshub | 04/20/2020 5:47:24 PM |
This is my letter to the shorts with | dinogreeves | investorshub | 04/18/2020 9:04:27 PM |
If this happens the stock will shoot up | dinogreeves | investorshub | 04/18/2020 3:47:56 PM |
News could come from GI*LD that there is | dinogreeves | investorshub | 04/18/2020 3:24:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Arcus Biosciences Inc. Company Name:
RCUS Stock Symbol:
NYSE Market:
Arcus Biosciences Inc. Website:
Updated data from EDGE-Gastric evaluating domvanalimab plus zimberelimab and chemotherapy in upper gastrointestinal (GI) cancers will be presented in a special ASCO plenary series rapid abstract update session by Yelena Y. Janjigian, M.D., Chief Gastrointestinal Oncology, Memorial Sloan Kettering...
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will host a conference call and webcast on Wednesday, May 8 th , 2024 at 1:30 P...
2024-04-14 06:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...